Open original FDA record ↗Recall record
- FDA identifier
- Z-0125-2015
- Company in FDA record
- Trivascular, Inc
- FDA classification date
- Nov 3, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
TriVascular has identified select lots of Ovation Prime 29mm Aortic Body stent grafts that may be associated with rapid emptying of the fill polymer syringe when it is connected to the Autoinjector during the fill polymer injection step of the primary implant procedure.
Source facts
- Action
- Urgent Field Safety Notice letter was sent to all consignees on 9/19/14 via trackable mail system. Users are notified that TriVascular has identified select lots of Ovation Prime 29mm Aortic Body stent grafts that may be associated with rapid emptying of the fill polymer syringe when it is connected to the Autoinjector during the fill polymer injection step of the primary implant procedure.
- Initiated
- 2014-09-20
- Root cause
- Under Investigation by firm
- Terminated
- 2014-12-04
- Distribution
- International Distribution Only -- Canada, Turkey, Austria, Ireland, Belgium, Italy, Switzerland, Spain, France, and Cyprus.
- Recall number
- Z-0125-2015
- Recall status
- Terminated
- CDRH record ID
- 130243
- FDA classified
- 2014-11-03
- Recall event number
- 69326